Your browser doesn't support javascript.
loading
Development and performance characteristics of novel code-based algorithms to identify invasive Escherichia coli disease.
Fortin, Stephen P; Hernandez Pastor, Luis; Doua, Joachim; Sarnecki, Michal; Swerdel, Joel; Colasurdo, Jamie; Geurtsen, Jeroen.
Affiliation
  • Fortin SP; Janssen Research & Development, Observational Health Data Analytics, Raritan, New Jersey, USA.
  • Hernandez Pastor L; Janssen Research & Development, Infectious Diseases and Vaccines, Beerse, Belgium.
  • Doua J; Janssen Research & Development, Infectious Diseases and Vaccines, Beerse, Belgium.
  • Sarnecki M; Janssen Vaccines, Branch of Cilag GmbH International, Bern, Switzerland.
  • Swerdel J; Janssen Research & Development, Observational Health Data Analytics, Raritan, New Jersey, USA.
  • Colasurdo J; Janssen Research & Development, Epidemiology, Raritan, New Jersey, USA.
  • Geurtsen J; Janssen Vaccines & Prevention, Bacterial Vaccines Research & Early Development, CN, Leiden, Netherlands.
Pharmacoepidemiol Drug Saf ; 31(9): 983-991, 2022 09.
Article in En | MEDLINE | ID: mdl-35753071
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Algorithms / Electronic Health Records Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Algorithms / Electronic Health Records Type of study: Prognostic_studies Limits: Humans Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2022 Type: Article Affiliation country: United States